Analysts expect SANUWAVE Health, Inc. to report revenue of 6.72 M for Q3 21, against a range of 6.28 M to 7.15 M. The most recent reported quarter, Q2 26, came in at 9.74 M, a 10.7% miss against the 10.91 M consensus.
| Metric | Q3 21 | Q4 21 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | 9.34 M | 10.16 M | 11.45 M | 13.39 M | 9.62 M | 9.74 M | - | - | - | - | - | - | ||||
| High Estimate | 7.15 M | 8.22 M | - | 9.97 M | 12.67 M | 14.54 M | 11.17 M | 11.25 M | 15.72 M | 16.19 M | 12.77 M | 13.14 M | 20.24 M | 24.18 M | ||||
| Low Estimate | 6.28 M | 7.55 M | - | 8.91 M | 11.25 M | 13.63 M | 9.26 M | 10.56 M | 13.53 M | 14.65 M | 10.67 M | 10.92 M | 16.69 M | 22.20 M | ||||
| Consensus Estimate | 6.72 M | 7.89 M | - | 9.44 M | 11.96 M | 14.08 M | 10.21 M | 10.91 M | 14.63 M | 15.42 M | 11.72 M | 12.03 M | 18.46 M | 23.19 M |
Analysts expect SANUWAVE Health, Inc. to report earnings per share of 0.00 for Q3 21, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at -0.08, a 166.7% miss against the -0.03 consensus.
| Metric | Q3 21 | Q4 21 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | -0.66 | 0.01 | 0.46 | - | -0.17 | -0.08 | - | - | - | - | - | |||||
| High Estimate | 0.00 | 0.00 | - | -0.08 | 0.34 | 0.19 | -0.14 | -0.03 | 0.01 | 0.07 | 0.32 | 0.41 | 0.22 | |||||
| Low Estimate | 0.00 | 0.00 | - | -0.10 | 0.28 | 0.15 | -0.16 | -0.03 | 0.01 | 0.07 | 0.30 | 0.37 | 0.18 | |||||
| Consensus Estimate | 0.00 | 0.00 | - | -0.09 | 0.31 | 0.17 | -0.15 | -0.03 | 0.01 | 0.07 | 0.31 | 0.39 | 0.20 |